Overall, our results support the importance of synaptic dysfunction and astrocytic activation in AD and highlight the potential value of therapeutic strategies that simultaneously protect synapses and modulate amyloid, tau, and glial responses [71]. Here, MAPT is linked to Alzheimer disease.